Bioactive Compounds
-
C3136 P32/98 (hemifumarate)Summary: competitive transition-state substrate analog inhibitor of DPP IV -
C3250 Ubiquitin Isopeptidase Inhibitor ISummary: ubiquitin isopeptidase inhibitor -
C4237 SQ 29,548Summary: TP receptor antagonist -
C3340 3MB-PP1Summary: polo-like kinase 1 (Plk1) allele inhibitor,ATP-competitive -
C3888 JGB1741Summary: SIRT1 inhibitor -
C4064 W123Summary: S1P1 antagonist -
C4594 bis(7)-TacrineSummary: AChE inhibitor -
C5540 4β-hydroxy CholesterolSummary: marker for CYP3A4/5 activity -
C5452 Monoacylglycerol Lipase Inhibitor 21Summary: inhibitor of monoacylglycerol lipase (MAGL) and FAAH -
C5518 γ-Linolenic Acid1 CitationSummary: weak LTB4 receptor antagonist

